EP2844067A4 - Oral tablet formulation consisting of immediate release rosuv astatin and extended release metformin - Google Patents

Oral tablet formulation consisting of immediate release rosuv astatin and extended release metformin

Info

Publication number
EP2844067A4
EP2844067A4 EP13765204.6A EP13765204A EP2844067A4 EP 2844067 A4 EP2844067 A4 EP 2844067A4 EP 13765204 A EP13765204 A EP 13765204A EP 2844067 A4 EP2844067 A4 EP 2844067A4
Authority
EP
European Patent Office
Prior art keywords
rosuv
astatin
tablet formulation
oral tablet
formulation consisting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13765204.6A
Other languages
German (de)
French (fr)
Other versions
EP2844067A1 (en
Inventor
Marie Charmaine Dias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALTHERA LIFE SCIENCES LLC
Original Assignee
ALTHERA LIFE SCIENCES LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALTHERA LIFE SCIENCES LLC filed Critical ALTHERA LIFE SCIENCES LLC
Publication of EP2844067A1 publication Critical patent/EP2844067A1/en
Publication of EP2844067A4 publication Critical patent/EP2844067A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP13765204.6A 2012-03-19 2013-03-15 Oral tablet formulation consisting of immediate release rosuv astatin and extended release metformin Withdrawn EP2844067A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261612563P 2012-03-19 2012-03-19
US201261640971P 2012-05-01 2012-05-01
PCT/US2013/031986 WO2013142314A1 (en) 2012-03-19 2013-03-15 Oral tablet formulation consisting of immediate release rosuv astatin and extended release metformin

Publications (2)

Publication Number Publication Date
EP2844067A1 EP2844067A1 (en) 2015-03-11
EP2844067A4 true EP2844067A4 (en) 2015-11-25

Family

ID=49223247

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13765204.6A Withdrawn EP2844067A4 (en) 2012-03-19 2013-03-15 Oral tablet formulation consisting of immediate release rosuv astatin and extended release metformin

Country Status (3)

Country Link
EP (1) EP2844067A4 (en)
MX (1) MX2014011167A (en)
WO (1) WO2013142314A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075933A1 (en) * 2002-03-07 2003-09-18 Upsher-Smith Laboratories, Inc. Composition for reducing blood glucose and cholesterol
EP1510208A1 (en) * 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
WO2011081493A2 (en) * 2009-12-30 2011-07-07 Bcworld Pharm. Co., Ltd. Pharmaceutical composition comprising metformin and rosuvastatin
US20110217374A1 (en) * 2009-10-09 2011-09-08 Yungjin Pharm. Co., Ltd. pharmaceutical composition simultaneously having rapid-acting property and long-acting property

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
CA2600736A1 (en) * 2005-03-16 2006-09-21 Dr. Reddy's Laboratories Ltd. Delivery system for multiple drugs
EP1970053A1 (en) * 2007-03-14 2008-09-17 Boehringer Ingelheim Pharma GmbH & Co. KG Pharmaceutical composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075933A1 (en) * 2002-03-07 2003-09-18 Upsher-Smith Laboratories, Inc. Composition for reducing blood glucose and cholesterol
EP1510208A1 (en) * 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
US20110217374A1 (en) * 2009-10-09 2011-09-08 Yungjin Pharm. Co., Ltd. pharmaceutical composition simultaneously having rapid-acting property and long-acting property
WO2011081493A2 (en) * 2009-12-30 2011-07-07 Bcworld Pharm. Co., Ltd. Pharmaceutical composition comprising metformin and rosuvastatin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2013142314A1 *

Also Published As

Publication number Publication date
WO2013142314A1 (en) 2013-09-26
MX2014011167A (en) 2014-11-14
EP2844067A1 (en) 2015-03-11

Similar Documents

Publication Publication Date Title
IL274988A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
HK1255336A1 (en) Pharmaceutical formulations and processes of preparation thereof
HK1203149A1 (en) Novel dosage form and formulation of abediterol
HK1203050A1 (en) Novel dosage and formulation
HK1214519A1 (en) Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof
HK1198466A1 (en) Prasugrel-containing immediate release stable oral pharmaceutical compositions
HUE043942T2 (en) Pharmaceutical composition with slow release of trimetazidine
PL2809305T3 (en) Bilayer tablet formulations of flurbiprofen and glucosamin
EP2844067A4 (en) Oral tablet formulation consisting of immediate release rosuv astatin and extended release metformin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20141017

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20151026

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/06 20060101ALI20151020BHEP

Ipc: A61P 3/10 20060101ALI20151020BHEP

Ipc: A61K 31/505 20060101ALI20151020BHEP

Ipc: A61K 31/155 20060101ALI20151020BHEP

Ipc: A61K 9/20 20060101AFI20151020BHEP

17Q First examination report despatched

Effective date: 20190528

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20201110